Home / PNPLA2 Knockout Cell Lines

PNPLA2 Knockout Cell Lines

Gene: PNPLA2

Official Full Name: patatin like domain 2, triacylglycerol lipaseprovided by HGNC

Gene Summary: This gene encodes an enzyme which catalyzes the first step in the hydrolysis of triglycerides in adipose tissue. Mutations in this gene are associated with neutral lipid storage disease with myopathy. [provided by RefSeq, Jul 2010]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO02846 PNPLA2 Knockout cell line (HeLa) Human PNPLA2 1:3~1:6 Negative Online Inquiry
KO02847 PNPLA2 Knockout cell line (HCT 116) Human PNPLA2 1:2~1:4 Negative Online Inquiry
KO02848 PNPLA2 Knockout cell line (HEK293) Human PNPLA2 1:3~1:6 Negative Online Inquiry
KO02849 PNPLA2 Knockout cell line (A549) Human PNPLA2 1:3~1:4 Negative Online Inquiry

Background

PNPLA2 Gene Knockout Cell Lines are specialized biological products designed to facilitate advanced genetic research by providing researchers with cell lines in which the PNPLA2 gene has been completely inactivated. The PNPLA2 gene encodes for a key enzyme involved in lipid metabolism, particularly in the process of lipolysis, where stored lipids are broken down into free fatty acids and glycerol. By producing knockout cell lines, researchers can effectively study the role of the PNPLA2 gene in various biological processes and potentially elucidate its involvement in metabolic disorders, obesity, and other related conditions.

The primary function of PNPLA2 knockout cell lines lies in their ability to serve as critical tools for examining the genetic and biochemical pathways affected by the absence of this enzyme. Researchers employ these cell lines to explore the impact of PNPLA2 deficiency on cellular lipid homeostasis, examining how its absence influences energy metabolism, adipocyte differentiation, and inflammation responses. The knockout approach allows for precise dissection of biological mechanisms in a controlled environment, presenting a powerful platform for drug discovery and testing potential therapeutic interventions targeting lipid metabolism abnormalities.

In terms of scientific importance, these knockout cell lines are invaluable in both academic and clinical research settings. They can provide insights into the molecular mechanisms underlying metabolic syndromes and cardiovascular diseases, thereby facilitating the development of new strategies for disease prevention and management. Furthermore, PNPLA2 knockout models can aid in evaluating drug efficacy and safety in a relevant biological context, making them essential tools for translational research.

The unique advantages of our PNPLA2 gene knockout cell lines include their meticulously characterized genetic background and consistent performance across experiments. Unlike conventional methods, which often rely on transient gene silencing techniques that can lead to variable results, our knockout cell lines provide stable and reproducible models, ensuring greater reliability of experimental outcomes.

Target users, including researchers and clinicians focused on metabolic diseases, will find immense value in utilizing these specialized cell lines. Their ability to provide a clear understanding of the PNPLA2 gene's role can foster innovative treatments that could lead to improved health outcomes for a wide range of individuals.

Our company stands at the forefront of genetic research products, backed by a commitment to quality and innovation. With extensive experience in developing specialized biological tools, we offer researchers reliable solutions that enable groundbreaking discoveries in the field of molecular biology and medicine.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.